Bank of America
CGEM icon

Bank of America’s Cullinan Oncology CGEM Stock Holding History

Bank of America’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.34M Buy
516,724
+170,417
+49% +$2.19M ﹤0.01% 3181
2025
Q4 		$3.58M Sell
346,307
-210,882
-38% -$1.9M ﹤0.01% 3643
2025
Q3 		$3.3M Sell
557,189
-104,096
-16% -$762K ﹤0.01% 4387
2025
Q2 		$4.98M Buy
661,285
+136,900
+26% +$1.1M ﹤0.01% 3904
2025
Q1 		$3.97M Buy
524,385
+369,115
+238% +$3.54M ﹤0.01% 4048
2024
Q4 		$1.89M Sell
155,270
-254,523
-62% -$3.66M ﹤0.01% 4494
2024
Q3 		$6.86M Sell
409,793
-2,952
-0.7% -$52.4K ﹤0.01% 3439
2024
Q2 		$7.2M Buy
412,745
+281,396
+214% +$5.99M ﹤0.01% 3272
2024
Q1 		$2.24M Sell
131,349
-4,063
-3% -$62.8K ﹤0.01% 4357
2023
Q4 		$1.38M Buy
135,412
+32,095
+31% +$284K ﹤0.01% 4732
2023
Q3 		$935K Buy
103,317
+83,529
+422% +$870K ﹤0.01% 4858
2023
Q2 		$213K Sell
19,788
-66,413
-77% -$705K ﹤0.01% 5787
2023
Q1 		$882K Buy
86,201
+16,372
+23% +$180K ﹤0.01% 4979
2022
Q4 		$737K Buy
69,829
+6,930
+11% +$84.2K ﹤0.01% 5090
2022
Q3 		$806K Buy
62,899
+34,227
+119% +$461K ﹤0.01% 5042
2022
Q2 		$367K Sell
28,672
-16,761
-37% -$190K ﹤0.01% 5642
2022
Q1 		$475K Buy
45,433
+16,384
+56% +$221K ﹤0.01% 5875
2021
Q4 		$448K Buy
29,049
+19,785
+214% +$395K ﹤0.01% 5973
2021
Q3 		$209K Sell
9,264
-5,372
-37% -$144K ﹤0.01% 6280
2021
Q2 		$376K Sell
14,636
-8,699
-37% -$268K ﹤0.01% 5642
2021
Q1 		$972K Buy
+23,335
New +$947K ﹤0.01% 4850

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bank of America's CGEM Position: Q1 2026 in Review

Bank of America increased its Cullinan Oncology (CGEM) stake by 49% in Q1 2026, buying an estimated $2.19M and bringing the position to 516,724 shares worth $7.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3181.

Bank of America first reported a position in CGEM in Q1 2021 and has held it in 21 quarters since. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Bank of America held 516,724 shares of Cullinan Oncology worth $7.34M as of Q1 2026.
  • Bank of America bought 170,417 Cullinan Oncology shares in Q1 2026, an estimated $2.19M.
  • Cullinan Oncology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3181 holding.
  • Bank of America first reported a position in Cullinan Oncology in Q1 2021 and has held it in 21 quarters since.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.